首页 工具
登录
购物车

搜索结果

Search Results for " p38β "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T67830 p38α inhibitor 3

p38 MAPK MAPK
p38α inhibitor 3是一种丝裂原活化蛋白激酶P38α的抑制剂,可以有效阻断成肌细胞分化。
T67944 p38 MAP Kinase Inhibitor Ⅵ

p38 MAPK MAPK
p38 MAP Kinase Inhibitor Ⅵ是一种有效的p38 MAP Kinase 抑制剂,具有抗炎活性。
T78652 p38α inhibitor 4

p38 MAPK MAPK
p38α inhibitor 4 是一种选择性 MAPK p38α抑制剂,看而用于研究糖尿病、疼痛和慢性炎症。
T36010 p38 MAPK Inhibitor

p38 MAPK MAPK
p38 MAPK Inhibitor 是p38 MAPK 激酶的有效抑制剂(IC50= 35 nM)。p38 MAPK Inhibitor 抑制癌基因RAS 诱导的衰老。
T16812 RWJ-67657

JNJ 3026582

p38 MAPK MAPK
RWJ-67657 (JNJ 3026582) 是一种可口服的选择性p38α和p38β抑制剂,IC50分别为 1 和 11 μM。它是心脏保护剂,具有抗炎和抗肿瘤活性。
T6927 Pamapimod

R1503,帕吡莫德,Ro4402257

p38 MAPK; Autophagy Autophagy; MAPK
Pamapimod (R1503) 是一种新型的选择性 p38 丝裂原活化蛋白激酶抑制剂,对于p38α和p38β的IC50分别为 14 nM 和 480 nM,Ki 分别为 1.3 nM 和 120 nM,对 p38δ 或 p38γ 亚型没有活性,可研究类风湿关节炎和其他自身免疫性疾病。
T36012 p38α inhibitor 2

p38α inhibitor 2 is a highly potent and selective p38α MAPK inhibitor, with a pIC50 of 9.6. p38α inhibitor 2 inhibits the hERG ion channel (IC50=27 μM) and shows a promising selectivity profile when tested in a panel of 51 other protein kinases (<30% inhibition at 10 μM concentration) and a panel of 141 other biological targets[1]. [1]. Raubo P, et al. The discovery and evaluation of 3-amino-2(1H)-pyrazinones as a novel series of selective p38α MAP kinase inhibitors [published online ahead of pr...
T36011 p38 MAP Kinase Inhibitor IV

p38 MAPK Inhibitor IV

p38 MAPK inhibitor IV is an ATP-competitive inhibitor of p38 MAP kinases with IC50 values of 0.13, 0.55, 5.47, and 8.63 μM for p38α, p38β, p38x, and p38δ, respectively, in vitro.[1] It also inhibits LPS-induced TNF-α and IL-1β cytokine production (IC50s = 22 and 44 nM, respectively) in human peripheral blood mononuclear cells.
T35420 (S)-p38 MAPK Inhibitor III

(S)-p38 MAPK Inhibitor III

(S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively).
T79028 p38 Kinase inhibitor 4

p38 MAPK MAPK
p38 Kinase inhibitor 4 (compound 135) 是高效的 p38 MAP Kinase 抑制剂,具有显著的生物活性。
T81441 PLK1/p38γ-IN-1

p38 MAPK MAPK
PLK1/p38γ-IN-1(化合物14)为PLK1与p38γ多靶点抑制剂,体外有效抑制人肝细胞癌与肝母细胞瘤细胞增殖。
T61803 p38 MAPK-IN-3

p38 MAPK-IN-3 (Compound 2c) is a potent inhibitor of p38α MAPK, displaying antitumor properties by promoting apoptosis and increasing reactive oxygen species (ROS) production [1].
T1974 PH-797804

PH797804

p38 MAPK; Autophagy Autophagy; MAPK
PH-797804 是一种 ATP 竞争性的,选择性的p38α/p38β抑制剂,对 p38α 的IC50为 26 nM,Ki 值为 5.8 nM,对 p38β 的Ki 值为 40 nM。
T10277 AL 8697

p38 MAPK MAPK
AL 8697 是一种特异性 p38α MAPK 抑制剂 (IC50 = 6 nM),其特异性是 p38β (IC50 = 82 nM) 的 14 倍,是其他 91 种激酶的 300 倍。 AL 8697 具有抗炎活性。
T12871 Talmapimod

他匹莫德,SCIO-469

p38 MAPK MAPK
Talmapimod (SCIO-469) 是 选择性的,具有口服活性的,ATP 竞争性的 p38α抑制剂,对 p38α和 p38β的 IC50 值分别是 9 nM 和90 nM。Talmapimod 在 20 个其他激酶 (包括其他 MAPKs) 上显示出至少 2000 倍的选择性。
T6089 Neflamapimod

VX-745

p38 MAPK; Autophagy Autophagy; MAPK
Neflamapimod (VX-745) 是一种可穿过血脑屏障的,高选择性的p38α抑制剂,对 p38α 的IC50值为 10 nM,p38β 的IC50值为 220 nM。它对 p38β 的特异性高 22 倍,具有抗炎活性。
T12997 SR-318

p38 MAPK; TNF Apoptosis; MAPK
SR-318 是p38 MAPK 的选择性抑制剂,对 p38α,p38β 和 p38α/β 的IC50分别为 5 nM,32 nM 和 6.11 μM。它有效抑制全血中TNF-α的释放,IC50为 283 nM。它显示出抗癌和抗炎活性。
T7661 SD-169

SD 169,1H-吲哚-5-甲酰胺

p38 MAPK MAPK
SD-169 (SD 169) 是一种可口服的 ATP 竞争性MAPK p38α抑制剂,IC50值为 3.2 nM。它对p38β MAPK 的IC50值为 122 nM。它通过抑制 T 细胞的浸润和活化阻止糖尿病的发展。
T2513 VX-702

p38 MAPK; Autophagy Autophagy; MAPK
VX702 是一种高度特异性的 p38α MAPK 抑制剂,对 p38α 的选择性比 p38β 高 14 倍。它是一种小分子研究口服抗细胞因子疗法,用于治疗炎症性疾病,如类风湿性关节炎。
T4597 UM-164

UM164,DAS-DFGO-II

p38 MAPK; Src; Autophagy Angiogenesis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
UM-164 (DAS-DFGO-II) 是一种高效的c-Src 抑制剂,Kd 为 2.7 nM。它还抑制p38α和p38β活性。
T6150 TAK-715

p38 MAPK; Casein Kinase; JNK MAPK; Metabolism; Stem Cells
TAK-715 是一种具有口服活性的p38 MAPK 抑制剂,对 p38α 和 p38β 的IC50分别为 7.1 nM 和200 nM。它抑制酪蛋白激酶 I (CK1δ/ε),调节 Wnt/β-catenin 信号传导的激活,有抗炎活性。
T2277 Losmapimod

GSK-AHAB,GW856553X,6-[5-(环丙基氨基甲酰基)-3-氟-2-甲基苯基]-N-(2,2-二甲基丙基)吡啶-3-甲酰胺,GW856553,洛批莫德,SB856553

p38 MAPK; Autophagy Autophagy; MAPK
Losmapimod (GSK-AHAB) 是一种可口服的特异性 p38 MAPK 抑制剂,抑制 p38α 和 p38β 的 pKi 值分别为 8.1 和 7.6。
T12871L Talmapimod hydrochloride

SCIO-469 hydrochloride

p38 MAPK MAPK
Talmapimod hydrochloride is a selective and ATP-competitive p38α inhibitor (IC50: 9 nM). It also shows about 10-fold selectivity over p38β, and at least 2000-fold selectivity over a panel of 20 other kinases, including other MAPKs.
T6976 SB 239063

SB239063

p38 MAPK; Autophagy Autophagy; MAPK
SB 239063 (SB239063) 是一种选择性、可口服的 p38 MAPK 抑制剂,对重组纯化的人 p38α 的 IC50值为 44 nM,具有抗哮喘作用,还被用于增强因衰老或疾病受损的记忆,如阿尔茨海默病。
T16477 PF-03715455

p38 MAPK MAPK
PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respective IC50: 0.88 and 23 nM). PF-0371545
T18682 SJFδ

Others Others
SJFδ is a 10-atom linker PROTAC. SJFδ degrades p38δ with a DC50 of 46.17 nM, but does not degrade p38α, p38β, or p38γ[1].
T10298L AMG-548

p38 MAPK MAPK
AMG-548 is an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ and is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM
T10298 AMG-548 hydrochloride (864249-60-5 free base)

AMG-548 hydrochloride

p38 MAPK MAPK
AMG-548 hydrochloride is an orally active and selective p38α inhibitor (Ki: 0.5 nM) and shows slightly selective over p38β (Ki: 36 nM) and >1000 fold selective against p38γ/p38δ. It is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50: 3 nM).
T7162 R1487 Hydrochloride

R1487 (Hydrochloride)

p38 MAPK; Autophagy Autophagy; MAPK
R1487 Hydrochloride (R1487(Hydrochloride)) 是一种可口服的高选择性 p38α 抑制剂,对 p38α 和 p38β 的Kd 值分别为 0.2 nM 和 29 nM。
T63371 AMG-548 hydrochloride

AMG-548 hydrochloride 是选择性的、口服具有活力的 p38α 抑制剂,Ki 值为 0.5 nM,对p38β略有选择性 (Ki=36 nM) 并且对 p38γ 和 p38δ 具有高于1000 倍的选择性。AMG 548 hydrochloride 同时能够有效抑制全血 LPS 刺激的TNFα,IC50值为 3 nM。AMG-548 hydrochloride 能够直接抑制酪蛋白激酶 1 (Casein kinase 1) 同种型 δ 和 ε ,进而对 Wnt 信号传导具有抑制作用。
T63762 AMG-548 dihydrochloride

AMG-548 dihydrochloride 是选择性的、口服具有活力的 p38α 抑制剂,Ki 值为 0.5 nM,对 p38β略有选择性 (Ki=36 nM) 并且对 p38γ 和 p38δ 具有 >1000 倍的选择性。AMG-548 dihydrochloride 对全血 LPS 刺激的 TNFα 表现出抑制作用,IC50 值为 3 nM。AMG-548 dihydrochloride 能够直接抑制酪蛋白激酶 1 (Casein kinase 1) 同种型 δ 和 ε ,并抑制 Wnt 信号传导。
T10298L2 AMG-548 dihydrochloride (864249-60-5 free base)

AMG-548 dihydrochloride

p38 MAPK MAPK
AMG-548 dihydrochloride is an orally active and selective p38α inhibitor (Ki: 0.5 nM) and shows slightly selective over p38β (Ki: 36 nM) and >1000 fold selective against p38γ/p38δ. It is also extremely potent in the inhibition of whole blood LPS stimulate
T36260 NR 7h

Potent and selective p38α and p38β degrader (DC50 < 50 nM). Displays no significant degradation of p38γ, p38δ, JNK1/2 or ERK1/2. Inhibits phosphorylation of MK2 in UV-treated cancer cells and LPS-stimulated bone marrow-derived macrophages (BMDM). Exhibits similar effect to p38α gene knockout in BBL358 cells. Active in vivo.
T2301 SB 202190

FHPI,SB202190

Apoptosis; p38 MAPK; Autophagy Apoptosis; Autophagy; MAPK
SB 202190 (FHPI) 是一种 p38 MAPK 抑制剂,可以抑制 p38α 和 p38β2 (IC50=50/100 nM),具有选择性和细胞渗透性。SB 202190 具有抗肿瘤活性,还可以诱导人胚胎干细胞向心肌细胞分化。
T37581 SCIO 469 hydrochloride

Selective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38α in vitro). Displays approximately 10-fold selectivity for p38α over p38β and 2000-fold selectivity for p38α over 20 other kinases. Reduces p38α phosphorylation in multiple myeloma cells in vitro and in vivo; activity results in decreased tumor burden and angiogenesis in murine models of multiple myeloma. Also enhances bortezomib-induced cytotoxicity against multiple myeloma cells. Hideshima et al (2004) p38 MAPK inhibition enhances P...
T70638 p38-α MAPK-IN-5

p38-α MAPK-IN-5 是一种有效的 p38α抑制剂,对 p38α、p38 β、p38γ、p38δ 的 IC50分别为 0.1 nM、0.2 nM、944 nM、4100 nM。p38-α MAPK-IN-5 具有抗炎作用,并且具有用于哮喘和慢性阻塞性肺病 (COPD) 研究的潜力。
T16721 Ralimetinib

LY2228820

Others Others
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor of p38 MAPK α/β (IC50s: 5.3 and 3.

化合物

p38α inhibitor 3
Cat.No: T67830
Synonym:
Target: p38 MAPK
p38 MAP Kinase Inhibitor Ⅵ
Cat.No: T67944
Synonym:
Target: p38 MAPK
p38α inhibitor 4
Cat.No: T78652
Synonym:
Target: p38 MAPK
p38 MAPK Inhibitor
Cat.No: T36010
Synonym:
Target: p38 MAPK
RWJ-67657
Cat.No: T16812
Synonym: JNJ 3026582
Target: p38 MAPK
Pamapimod
Cat.No: T6927
Synonym: R1503,帕吡莫德,Ro4402257
Target: p38 MAPK, Autophagy
p38α inhibitor 2
Cat.No: T36012
Synonym:
Target:
p38 MAP Kinase Inhibitor IV
Cat.No: T36011
Synonym: p38 MAPK Inhibitor IV
Target:
(S)-p38 MAPK Inhibitor III
Cat.No: T35420
Synonym: (S)-p38 MAPK Inhibitor III
Target:
p38 Kinase inhibitor 4
Cat.No: T79028
Synonym:
Target: p38 MAPK
PLK1/p38γ-IN-1
Cat.No: T81441
Synonym:
Target: p38 MAPK
p38 MAPK-IN-3
Cat.No: T61803
Synonym:
Target:
PH-797804
Cat.No: T1974
Synonym: PH797804
Target: p38 MAPK, Autophagy
AL 8697
Cat.No: T10277
Synonym:
Target: p38 MAPK
Talmapimod
Cat.No: T12871
Synonym: 他匹莫德,SCIO-469
Target: p38 MAPK
Neflamapimod
Cat.No: T6089
Synonym: VX-745
Target: p38 MAPK, Autophagy
SR-318
Cat.No: T12997
Synonym:
Target: p38 MAPK, TNF
SD-169
Cat.No: T7661
Synonym: SD 169,1H-吲哚-5-甲酰胺
Target: p38 MAPK
VX-702
Cat.No: T2513
Synonym:
Target: p38 MAPK, Autophagy
UM-164
Cat.No: T4597
Synonym: UM164,DAS-DFGO-II
Target: p38 MAPK, Src, Autophagy
TAK-715
Cat.No: T6150
Synonym:
Target: p38 MAPK, Casein Kinase, JNK
Losmapimod
Cat.No: T2277
Synonym: GSK-AHAB,GW856553X,6-[5-(环丙基氨基甲酰基)-3-氟-2-甲基苯基]-N-(2,2-二甲基丙基)吡啶-3-甲酰胺,GW856553,洛批莫德,SB856553
Target: p38 MAPK, Autophagy
Talmapimod hydrochloride
Cat.No: T12871L
Synonym: SCIO-469 hydrochloride
Target: p38 MAPK
SB 239063
Cat.No: T6976
Synonym: SB239063
Target: p38 MAPK, Autophagy
PF-03715455
Cat.No: T16477
Synonym:
Target: p38 MAPK
SJFδ
Cat.No: T18682
Synonym:
Target: Others
AMG-548
Cat.No: T10298L
Synonym:
Target: p38 MAPK
AMG-548 hydrochloride (864249-60-5 free base)
Cat.No: T10298
Synonym: AMG-548 hydrochloride
Target: p38 MAPK
R1487 Hydrochloride
Cat.No: T7162
Synonym: R1487 (Hydrochloride)
Target: p38 MAPK, Autophagy
AMG-548 hydrochloride
Cat.No: T63371
Synonym:
Target:
AMG-548 dihydrochloride
Cat.No: T63762
Synonym:
Target:
AMG-548 dihydrochloride (864249-60-5 free base)
Cat.No: T10298L2
Synonym: AMG-548 dihydrochloride
Target: p38 MAPK
NR 7h
Cat.No: T36260
Synonym:
Target:
SB 202190
Cat.No: T2301
Synonym: FHPI,SB202190
Target: Apoptosis, p38 MAPK, Autophagy
SCIO 469 hydrochloride
Cat.No: T37581
Synonym:
Target:
p38-α MAPK-IN-5
Cat.No: T70638
Synonym:
Target:
Ralimetinib
Cat.No: T16721
Synonym: LY2228820
Target: Others
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼